Publications by authors named "Mark A Weiss"

Claim this Profile
D
Did border closures slow SARS-CoV-2?
Mary A Shiraef, Paul Friesen, Lukas Feddern, Mark A Weiss,

Sci Rep· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID Border Accountability Project, a hand-coded global database of border closures introduced during 2020.
Mary A Shiraef, Cora Hirst, Mark A Weiss, Sarah Naseer, Nikolas Lazar

Sci Data· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterizing and prognosticating chronic lymphocytic leukemia in the elderly: prospective evaluation on 455 patients treated in the United States.
Chadi Nabhan, Anthony Mato, Christopher R Flowers, David L Grinblatt, Nicole Lamanna, Mark A Weiss

BMC Cancer· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world clinical experience in the Connect chronic lymphocytic leukaemia registry: a prospective cohort study of 1494 patients across 199 US centres.
Anthony Mato, Chadi Nabhan, Neil E Kay, Mark A Weiss, Nicole Lamanna

Br J Haematol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy in acute myeloid leukemia.
Dolores A Grosso, Rosemary C Hess, Mark A Weiss

Cancer· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Posttreatment interleukin-2 in patients with acute myeloid leukemia: the end of a long road for patients and clinical trials?
Dolores Grosso, Mark A Weiss

Cancer· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liposomal vincristine for relapsed or refractory Ph-negative acute lymphoblastic leukemia: a review of literature.
Priyanka Pathak, Rosemary Hess, Mark A Weiss

Ther Adv Hematol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neanderthal and Denisova genetic affinities with contemporary humans: introgression versus common ancestral polymorphisms.
Robert K Lowery, Gabriel Uribe, Eric B Jimenez, Mark A Weiss, Kristian J Herrera

Gene· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of adults with acute lymphoblastic leukemia: do the specifics of the regimen matter?: Results from a prospective randomized trial.
Nicole Lamanna, Leonard T Heffner, Matt Kalaycio, Gary Schiller, Steven Coutre, Mark A Weiss

Cancer· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemoimmunotherapy with modified dosing of fludarabine, cyclophosphamide, and rituximab shows significant clinical activity in patients with previously untreated chronic lymphocytic leukemia.
Nicole Lamanna, Mark A Weiss

Curr Hematol Malig Rep· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential therapy with fludarabine, high-dose cyclophosphamide, and rituximab in previously untreated patients with chronic lymphocytic leukemia produces high-quality responses: molecular remissions predict for durable complete responses.
Nicole Lamanna, Joseph G Jurcic, Ariela Noy, Peter Maslak, Alison N Gencarelli, Mark A Weiss

J Clin Oncol· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consolidation and maintenance rituximab therapy in chronic lymphocytic leukemia.
Nicole Lamanna, Mark A Weiss

Curr Oncol Rep· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pentostatin in chronic lymphocytic leukemia.
Craig Sauter, Nicole Lamanna, Mark A Weiss

Expert Opin Drug Metab Toxicol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presentation of the PATH Alliance registry for prospective data collection and analysis of the epidemiology, therapy, and outcomes of invasive fungal infections.
David L Horn, Jay A Fishman, William J Steinbach, Elias J Anaissie, Kieren A Marr, Mark A Weiss

Diagn Microbiol Infect Dis· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pentostatin, cyclophosphamide, and rituximab show significant clinical activity in patients with previously untreated chronic lymphocytic leukemia.
Nicole Lamanna, Mark A Weiss

Curr Oncol Rep· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical trials report. Minimal residual disease quantification in adult acute lymphoblastic leukemia.
Heather Landau, Mark A Weiss

Curr Oncol Rep· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pentostatin, cyclophosphamide, and rituximab is an active, well-tolerated regimen for patients with previously treated chronic lymphocytic leukemia.
Nicole Lamanna, Matt Kalaycio, Peter Maslak, Joseph G Jurcic, Mark Heaney, Mark A Weiss

J Clin Oncol· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Purine analogue-based chemotherapy regimens for second-line therapy in patients with chronic lymphocytic leukemia.
Nicole Lamanna, Mark A Weiss

Semin Hematol· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety results with the LifeSite hemodialysis access system versus the Tesio-Cath hemodialysis catheter at 12 months.
Melvin Rosenblatt, James G Caridi, Faris Z Hakki, Jerry Jackson, Toros Kapoian, Mark A Weiss

J Vasc Interv Radiol· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory myofibroblastic tumors of the kidney: a clinicopathologic and immunohistochemical study of 12 cases.
Linda R Kapusta, Mark A Weiss, Jennifer Ramsay, Antonio Lopez-Beltran, John R Srigley

Am J Surg Pathol· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pentostatin and cyclophosphamide: an effective new regimen in previously treated patients with chronic lymphocytic leukemia.
Mark A Weiss, Peter G Maslak, Joseph G Jurcic, David A Scheinberg, Timothy B Aliff

J Clin Oncol· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin.
Timothy B Aliff, Peter G Maslak, Joseph G Jurcic, Mark L Heaney, Kathleen N Cathcart, Mark A Weiss

Cancer· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter clinical trial results with the LifeSite hemodialysis access system.
Steve J Schwab, Mark A Weiss, Fred Rushton, John P Ross, Jerry Jackson

Kidney Int· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A single, high dose of idarubicin combined with cytarabine as induction therapy for adult patients with recurrent or refractory acute lymphoblastic leukemia.
Mark A Weiss, Timothy B Aliff, Martin S Tallman, Stanley R Frankel, Matt E Kalaycio

Cancer· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis